Diversified Trust’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Buy
8,701
+377
+5% +$70.9K 0.03% 336
2026
Q1
$1.64M Buy
8,324
+5,131
+161% +$989K 0.03% 309
2025
Q4
$587K Buy
3,193
+207
+7% +$36.3K 0.01% 615
2025
Q3
$458K Sell
2,986
-577
-16% -$87.3K 0.01% 666
2025
Q2
$498K Buy
3,563
+528
+17% +$74K 0.01% 592
2025
Q1
$446K Buy
3,035
+220
+8% +$31.8K 0.01% 610
2024
Q4
$369K Buy
2,815
+154
+6% +$21.6K 0.01% 682
2024
Q3
$415K Sell
2,661
-4
-0.2% -$646 0.01% 645
2024
Q2
$416K Buy
2,665
+493
+23% +$74.2K 0.01% 592
2024
Q1
$294K Buy
2,172
+119
+6% +$15.8K 0.01% 655
2023
Q4
$276K Sell
2,053
-1,206
-37% -$157K 0.01% 690
2023
Q3
$441K Buy
3,259
+1,027
+46% +$140K 0.02% 502
2023
Q2
$319K Buy
2,232
+76
+4% +$11.2K 0.01% 603
2023
Q1
$299K Sell
2,156
-167
-7% -$22.5K 0.01% 621
2022
Q4
$315K Sell
2,323
-12
-0.5% -$1.5K 0.01% 569
2022
Q3
$256K Buy
2,335
+343
+17% +$43.5K 0.01% 599
2022
Q2
$263K Sell
1,992
-283
-12% -$37.1K 0.01% 604
2022
Q1
$302K Buy
2,275
+280
+14% +$33.6K 0.01% 615
2021
Q4
$232K Sell
1,995
-37
-2% -$4.35K 0.01% 723
2021
Q3
$244K Buy
+2,032
New +$237K 0.01% 660
2021
Q1
Sell
-6,475
Closed -$647K 771
2020
Q4
$647K Buy
+6,475
New +$686K 0.03% 277

Other funds holding AZN

Diversified Trust's AZN Position: Q2 2026 in Review

Diversified Trust increased its AstraZeneca (AZN) stake by 4.5% in Q2 2026, buying an estimated $70.9K and bringing the position to 8,701 shares worth $1.65M. The position accounts for 0.03% of the portfolio, ranked #336.

Diversified Trust first reported a position in AZN in Q4 2020 and has held it in 21 quarters since. 369 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Diversified Trust held 8,701 shares of AstraZeneca worth $1.65M as of Q2 2026.
  • Diversified Trust bought 377 AstraZeneca shares in Q2 2026, an estimated $70.9K.
  • AstraZeneca made up 0.03% of Diversified Trust's portfolio in Q2 2026, its #336 holding.
  • Diversified Trust first reported a position in AstraZeneca in Q4 2020 and has held it in 21 quarters since.
  • 369 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.